Prostate cancer is the most frequently diagnosed cancer in American men, and it is especially common in men over the age of 50. Nine out of 10 prostate cancers are classified as adenocarcinomas, which originate in the cells of the prostate gland. However, rare cancers may sometimes develop in the cells of the prostate ducts, the cells that line the urethra or the cells that cover the prostate gland.
At Moffitt Cancer Center, we take a unique, multispecialty approach to treating prostate cancer. Our Genitourinary Oncology Program is made up of medical professionals from a number of disciplines, allowing us to coordinate comprehensive, individualized care for each of our patients. Plus, these professionals solely treat patients with prostate cancer and similar genitourinary malignancies, making them some of the most experienced and highly specialized in their field. Every patient’s case is discussed at a weekly meeting (tumor board), where all oncologists and supportive care providers involved in the case come together to make recommendations for improving the patient’s outcome and quality of life.
Depending on each patient’s specific needs, we may recommend one or more of the following options, all of which we provide in one convenient location:
- Radiation therapy
- Biological therapy
Experimental therapies and clinical trials may also be an option. At Moffitt, we’re proud to have an exceptionally robust clinical trial program, so that patients can access cutting-edge therapies under the supervision of their primary oncologist. Because of our dedication to providing patients with the most expansive range of effective treatment options, we have been named a Comprehensive Cancer Center by the National Cancer Institute.
No referral is required to receive prostate cancer treatment at Moffitt. New patients can make an appointment by completing our new patient registration form, or they can call 1-888-MOFFITT to schedule a visit with our team.